Skye Bioscience to discontinue development of eye disease treatment
10/06/2024 12:15
June 10 (Reuters) - Skye Bioscience SKYE.O said on Monday it intends to discontinue development of its experimental eye disease treatment after it failed in a mid-stage study. (Reporting by Sneha S K in Bengaluru; Editing by Krishna Chandra Eluri) ((Sneha.SK@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsBrief: Skye Announces Cohort Review Committee Approved Opening Of Cohort 2 Based On Favorable Safety Data From First Four Participants Treated In Cohort 1
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Skye Bioscience rises as it begins testing higher doses of obesity drug